{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:34:19Z","timestamp":1760441659197,"version":"build-2065373602"},"reference-count":56,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health of the Slovak Republic","award":["2018\/45-SAV-4"],"award-info":[{"award-number":["2018\/45-SAV-4"]}]},{"name":"Scientific Grant Agency of the Ministry of Education, Science, Research and Sport o fthe Slovak Republic and the Slovak Academy of Sciences","award":["2\/0036\/19 and 2\/0102\/17"],"award-info":[{"award-number":["2\/0036\/19 and 2\/0102\/17"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The current guidelines for diagnosis, prognosis, and treatment of endometrial cancer (EC), based on clinicopathological factors, are insufficient for numerous reasons; therefore, we investigated the relevance of miRNA expression profiles for the discrimination of different EC subtypes. Among the miRNAs previously predicted to allow distinguishing of endometrioid ECs (EECs) according to different grades (G) and from serous subtypes (SECs), we verified the utility of miR-497-5p. In ECs, we observed downregulated miR-497-5p levels that were significantly decreased in SECs, clear cell carcinomas (CCCs), and carcinosarcomas (CaSas) compared to EECs, thereby distinguishing EEC from SEC and rare EC subtypes. Significantly reduced miR-497-5p expression was found in high-grade ECs (EEC G3, SEC, CaSa, and CCC) compared to low-grade carcinomas (EEC G1 and mucinous carcinoma) and ECs classified as being in advanced FIGO (International Federation of Gynecology and Obstetrics) stages, that is, with loco-regional and distant spread compared to cancers located only in the uterus. Based on immunohistochemical features, lower miR-497-5p levels were observed in hormone-receptor-negative, p53-positive, and highly Ki-67-expressing ECs. Using a machine learning method, we showed that consideration of miR-497-5p expression, in addition to the traditional clinical and histopathologic parameters, slightly improves the prediction accuracy of EC diagnosis. Our results demonstrate that changes in miR-497-5p expression influence endometrial tumorigenesis and its evaluation may contribute to more precise diagnoses.<\/jats:p>","DOI":"10.3390\/ijms22010127","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T22:56:45Z","timestamp":1608850605000},"page":"127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7581-1770","authenticated-orcid":false,"given":"Ivana","family":"Fridrichova","sequence":"first","affiliation":[{"name":"Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Kalinkova","sequence":"additional","affiliation":[{"name":"Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miloslav","family":"Karhanek","sequence":"additional","affiliation":[{"name":"Laboratory of Bioinformatics, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-5652","authenticated-orcid":false,"given":"Bozena","family":"Smolkova","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Machalekova","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Elisabeth Cancer Institute, 81250 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3000-6644","authenticated-orcid":false,"given":"Lenka","family":"Wachsmannova","sequence":"additional","affiliation":[{"name":"Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliia","family":"Nikolaieva","sequence":"additional","affiliation":[{"name":"Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 84505 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Kajo","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Elisabeth Cancer Institute, 81250 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/cncr.30094","article-title":"Endometrial cancer: Not your grandmother\u00b4s cancer","volume":"122","author":"McAlpine","year":"2016","journal-title":"Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: Have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: More than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11912-019-0825-z","article-title":"Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors","volume":"21","author":"Wortman","year":"2019","journal-title":"Curr. Oncol. Rep"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of molecular characteristics into endometrial cancer management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Delangle, R., De Foucher, T., Larsen, A.K., Sabbah, M., Aza\u00efs, H., Bendifallah, S., Dara\u00ef, E., Ballester, M., Mehats, C., and Uzan, C. (2019). The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis. Cancers, 11.","DOI":"10.3390\/cancers11060832"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Kandoth, C., Schultz, N., Cherniak, A.D., Akbani, R., Liu, Y., Shen, H., Robertson, A.G., Pashtan, I., and Shen., R. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497, 67\u201373.","DOI":"10.1038\/nature12113"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2017.05.011","article-title":"MicroRNAs in gynecological cancers: Small molecules with big implications","volume":"407","author":"Srivastava","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ijc.27840","article-title":"Diagnostic and prognostic significance of miRNA signatures in tissue and plasma of endometroid endometrial carcinoma patients","volume":"132","author":"Torres","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_13","first-page":"941","article-title":"Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer","volume":"32","author":"Canlorbe","year":"2017","journal-title":"Histol. Histopathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","article-title":"Machine learning applications in cancer prognosis and prediction","volume":"13","author":"Kourou","year":"2014","journal-title":"Comput. Struct Biotechnol. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1016\/S1470-2045(19)30149-4","article-title":"Big data and machine learning algorithms for health-care delivery","volume":"20","author":"Ngiam","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kalinkova, L., Kajo, K., Karhanek, M., Wachsmannova, L., Suran, P., Zmetakova, I., and Fridrichova, I. (2020). Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176071"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1002\/jcp.26272","article-title":"MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK\/ERK signaling pathway via RAF-1","volume":"233","author":"Tao","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"BSR20170270","DOI":"10.1042\/BSR20170270","article-title":"MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells","volume":"37","author":"Pengcheng","year":"2017","journal-title":"Biosci. Rep."},{"key":"ref_19","first-page":"443","article-title":"miR-497 suppresses malignant phenotype in non-small cell lung cancer via targeting KDR","volume":"42","author":"Xia","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/mmr.2016.5256","article-title":"Expression and function of microRNA-497 in human osteosarcoma","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/ol.2015.3981","article-title":"MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma","volume":"11","author":"Ding","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_22","first-page":"6379","article-title":"MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer","volume":"14","author":"Xu","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10535","DOI":"10.2147\/OTT.S210059","article-title":"MicroRNA-497-5p Induces Cell Cycle Arrest of Cervical Cancer Cells in S Phase by Targeting CBX4","volume":"12","author":"Chen","year":"2019","journal-title":"Oncol. Targets Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/onc.2017.315","article-title":"Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: The role of miR-497 in epithelial to mesenchymal transition of keratinocytes","volume":"37","author":"Mizrahi","year":"2018","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e7091","DOI":"10.7717\/peerj.7091","article-title":"Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer","volume":"7","author":"Xu","year":"2019","journal-title":"PeerJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1007\/s13277-015-4665-7","article-title":"miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/1061186X.2018.1479755","article-title":"MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma","volume":"27","author":"Qu","year":"2019","journal-title":"J. Drug Target."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.1007\/s13277-016-5200-1","article-title":"MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha","volume":"37","author":"Han","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.7150\/jca.25514","article-title":"Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysis","volume":"9","author":"Feng","year":"2018","journal-title":"J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1349-7006.2009.01385.x","article-title":"Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas","volume":"101","author":"Hiroki","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12967-018-1515-6","article-title":"Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer","volume":"16","author":"Sbeih","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Xu, X., Liu, T., Wang, Y., Fu, J., Yang, Q., Wu, J., and Zhou, H. miRNA-mRNA Associated With Survival in Endometrial Cancer. Front. Genet., 10, 743.","DOI":"10.3389\/fgene.2019.00743"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/PGP.0000000000000496","article-title":"International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group","volume":"38","author":"Cho","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Swasti (2018). Estrogen and Progesterone Receptors in Endometrial Cancer and Their Prognostic Relevance. Gynecol. Obstet., 8, e127.","DOI":"10.4172\/2161-0932.1000e127"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12672-019-0358-9","article-title":"Estrogen Signaling in Endometrial Cancer: A Key Oncogenic Pathway with Several Open Questions","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Horm. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"479541","DOI":"10.1155\/2013\/479541","article-title":"The estrogen receptor joins other cancer biomarkers as a predictor of outcome","volume":"2013","author":"Leslie","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2007.03.042","article-title":"Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: A Gynecologic Oncology Group Study","volume":"106","author":"Singh","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-9-77","article-title":"Distribution of estrogen and progesterone receptors isoforms in endometrial cancer","volume":"9","author":"Pricop","year":"2014","journal-title":"Diagn. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer\u2014A Swedish Gynecologic Cancer Group (SweGCG) study","volume":"58","author":"Bjurberg","year":"2019","journal-title":"Acta Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2009.02.038","article-title":"MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/cncr.25944","article-title":"Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells","volume":"117","author":"Wu","year":"2011","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"84384","DOI":"10.18632\/oncotarget.21037","article-title":"MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shu, S., Liu, X., Xu, M., Gao, X., Fan, J., Liu, H., and Li, R. (2018). MicroRNA-424 regulates epithelial-mesenchymal transition of endometrial carcinoma by directly targeting insulin-like growth factor 1 receptor. J. Cell Biochem, 120.","DOI":"10.1002\/jcb.27528"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e004007","DOI":"10.1136\/bmjopen-2013-004007","article-title":"Machine-learning prediction of cancer survival: A retrospective study using electronic administrative records and a cancer registry","volume":"4","author":"Gupta","year":"2014","journal-title":"BMJ Open"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/his.13155","article-title":"Implementation of an e-learning module improves consistency in the histopathological diagnosis of sessile serrated lesions within a nationwide population screening programme","volume":"70","author":"IJspeert","year":"2017","journal-title":"Histopathology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zhu, W., Xie, L., Han, J., and Guo, X. (2020). The Application of Deep Learning in Cancer Prognosis Prediction. Cancers, 12.","DOI":"10.3390\/cancers12030603"},{"key":"ref_48","first-page":"165","article-title":"Improving the Prediction of Survival in Cancer Patients by Using Machine Learning Techniques: Experience of Gene Expression Data: A Narrative Review","volume":"46","author":"Bashiri","year":"2017","journal-title":"Iran. J. Public Health"},{"key":"ref_49","unstructured":"Kurman, R.J., Carcangiu, M.L., Herrington, S., and Young, R.H. (2014). WHO Classification of Tumours of Female Reproductive Organs, IARC."},{"key":"ref_50","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Brierley, J.D., Gospodarowicz, M.K., and Wittekind, C. (2017). TNM Classification of Malignant Tumours, John Wiley and Sons, Inc.. [8th ed.].","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C[T]] Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_54","first-page":"2349","article-title":"Orange: Data Mining Toolbox in Python","volume":"14","author":"Demsar","year":"2013","journal-title":"J. Mach. Learn. Res."},{"key":"ref_55","first-page":"2825","article-title":"Scikit-learn: Machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0 Contributors. SciPy 1.0: Fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:54Z","timestamp":1760179554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ijms22010127"],"URL":"https:\/\/doi.org\/10.3390\/ijms22010127","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2020,12,24]]}}}